BOLT Bolt Biotherapeutics, Inc.

Fundamentals / CIK 0001641281 / USD

Bolt Biotherapeutics, Inc. reported $2.53M in revenue and a net loss of $26.18M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -1098.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BOLT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$18.17M$9.09M$0-$92.85MFY 2020 Revenue: $231KFY 2020 Net Income: -$60.73M2020FY 2021 Revenue: $1.26MFY 2021 Net Income: -$98.59M2021FY 2022 Revenue: $5.73MFY 2022 Net Income: -$88.10M2022FY 2023 Revenue: $7.88MFY 2023 Net Income: -$69.20M2023FY 2024 Revenue: $7.69MFY 2024 Net Income: -$63.12M2024FY 2025 Revenue: $7.70MFY 2025 Net Income: -$33.38M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $7.70M $7.69M $7.88M $5.73M $1.26M $231K
Research & Development $28.53M $57.47M $61.54M $73.12M $75.66M $40.36M
Total Operating Expenses $43.81M $80.74M $84.07M $96.05M $94.05M $49.41M
Operating Income -$36.11M -$73.05M -$76.20M -$90.32M -$92.79M -$49.18M
EBITDA -$34.82M -$71.27M -$74.34M -$88.66M -$91.59M -$48.57M
Income Before Tax -$33.38M -$63.12M -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$33.38M -$63.12M -$69.20M -$88.10M -$98.59M -$60.73M
Basic EPS -$17.40 -$33.06 -$1.83 -$2.36 -$2.97 -$28.89
Diluted EPS -$17.40 -$33.06 -$1.83 -$2.36 -$2.97 -$28.89
Basic Shares Outstanding 1.9M 1.9M 37.8M 37.4M 33.2M 2.0M
Diluted Shares Outstanding 1.9M 1.9M 37.8M 37.4M 33.2M 2.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $5.0K $26K $2.50M $2.17M $1.80M $1.22M $0
Research & Development $2.21M $4.72M $5.25M $4.99M $6.54M $7.50M $9.51M $11.72M
Total Operating Expenses $4.73M $7.95M $8.05M $9.59M $9.87M $11.01M $13.34M $16.92M
Operating Income -$4.73M -$7.95M -$8.03M -$7.08M -$7.70M -$9.21M -$12.12M -$16.92M
EBITDA -$4.66M -$7.78M -$7.82M -$6.83M -$7.41M -$8.86M -$11.72M -$16.49M
Net Income -$4.42M -$7.46M -$7.67M -$6.63M -$7.14M -$8.56M -$11.04M -$15.94M
Basic EPS -$2.25 -$3.88 -$3.99 -- -$3.72 -$4.46 -$5.76 --
Diluted EPS -$2.25 -$3.88 -$3.99 -- -$3.72 -$4.46 -$5.76 --
Basic Shares Outstanding 2.0M 1.9M 1.9M -- 1.9M 1.9M 1.9M --
Diluted Shares Outstanding 2.0M 1.9M 1.9M -- 1.9M 1.9M 1.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $11.70M $7.21M $10.81M $9.24M $27.38M $5.54M
Short-Term Investments $15.80M $40.12M $91.38M $159.6M $158.8M $17.30M
Cash & Short-Term Investments $31.80M $70.20M $128.6M $192.8M $186.2M $22.84M
Total Current Assets $30.26M $50.81M $105.7M $172.7M $189.2M $25.36M
Property, Plant & Equipment, Net $1.25M $3.14M $4.96M $6.45M $6.16M $4.08M
Long-Term Investments $4.34M $22.88M $26.41M $23.94M $85.35M --
Other Non-Current Assets $138K $62K $1.82M $1.03M $1.04M $909K
Total Non-Current Assets $26.49M $48.82M $54.08M $55.06M $118.6M $21.18M
Total Assets $56.75M $99.63M $159.8M $227.8M $307.7M $46.54M
Accounts Payable $1.44M $1.51M $2.99M $3.59M $3.57M $1.60M
Deferred Revenue (Current) $449K $3.02M $2.20M $1.40M $2.87M $1.50M
Total Current Liabilities $8.44M $15.86M $20.46M $23.12M $21.33M $11.26M
Deferred Revenue (Non-Current) $1.54M $3.62M $9.11M $12.92M $14.21M --
Other Non-Current Liabilities $132K $0 $43K $42K $210K $329K
Total Non-Current Liabilities $21.81M $26.58M $26.59M $33.18M $36.27M $34.93M
Total Liabilities $30.24M $42.43M $47.04M $56.30M $57.60M $46.19M
Total Debt (incl. Leases) $22.96M $25.21M $20.22M $22.61M $24.36M $10.88M
Common Stock $0 $0 $0 $0 $0 --
Retained Earnings -$460.8M -$427.4M -$364.3M -$295.1M -$207.0M -$108.4M
Accumulated Other Comp. Income -$21K $97K $37K -$919K -$321K --
Total Stockholders' Equity $26.50M $57.20M $112.7M $171.5M $250.1M -$104.9M
Total Equity $26.50M $57.20M $112.7M $171.5M $250.1M -$104.9M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $13.78M $12.86M $11.61M $11.70M $17.75M $9.60M $8.39M $7.21M
Short-Term Investments $1.02M $4.74M $11.28M $15.80M $14.16M $25.17M $30.45M $40.12M
Cash & Short-Term Investments $15.00M $18.10M $23.90M $31.80M $38.80M $48.50M $58.00M $70.20M
Total Current Assets $17.08M $20.56M $25.75M $30.26M $35.61M $38.34M $42.51M $50.81M
Property, Plant & Equipment, Net $341K $408K $1.04M $1.25M $1.50M $1.72M $2.06M $3.14M
Long-Term Investments $247K $509K $1.02M $4.34M $6.91M $13.72M $19.11M $22.88M
Other Non-Current Assets $18K $87K $112K $138K $179K $222K $51K $62K
Total Non-Current Assets $18.51M $19.62M $22.27M $26.49M $29.45M $37.16M $43.35M $48.82M
Total Assets $35.59M $40.18M $48.03M $56.75M $65.05M $75.50M $85.86M $99.63M
Accounts Payable $633K $868K $1.74M $1.44M $1.52M $1.85M $1.53M $1.51M
Deferred Revenue (Current) $1.07M $819K $630K $449K $1.91M $2.51M $3.08M $3.02M
Total Current Liabilities $8.31M $7.87M $7.77M $8.44M $9.97M $12.31M $13.56M $15.86M
Deferred Revenue (Non-Current) $924K $1.17M $1.35M $1.54M $1.96M $2.59M $3.05M $3.62M
Other Non-Current Liabilities $132K $132K $158K $132K $133K $133K $132K $0
Total Non-Current Liabilities $18.71M $19.84M $20.86M $21.81M $22.99M $24.35M $25.49M $26.58M
Total Liabilities $27.03M $27.70M $28.63M $30.24M $32.95M $36.66M $39.05M $42.43M
Total Debt (incl. Leases) $20.89M $21.62M $22.31M $22.96M $23.59M $24.18M $24.71M $25.21M
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$480.3M -$475.9M -$468.4M -$460.8M -$454.1M -$447.0M -$438.4M -$427.4M
Accumulated Other Comp. Income -$43K -$44K -$11K -$21K -$10K -$6.0K $40K $97K
Total Stockholders' Equity $8.56M $12.48M $19.40M $26.50M $32.10M $38.84M $46.81M $57.20M
Total Equity $8.56M $12.48M $19.40M $26.50M $32.10M $38.84M $46.81M $57.20M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$33.38M -$63.12M -$69.20M -$88.10M -$98.59M -$60.73M
Depreciation & Amortization $1.29M $1.78M $1.85M $1.67M $1.19M $611K
Stock-Based Compensation $2.78M $7.41M $9.22M $9.58M $8.50M $1.42M
Operating Cash Flow -$39.85M -$61.29M -$69.53M -$76.50M -$57.07M -$47.31M
Capital Expenditure -$72K -$41K -$206K -$1.95M -$2.34M -$3.26M
Free Cash Flow -$39.92M -$61.33M -$69.73M -$78.46M -$59.40M -$50.57M
Purchases of Investments -$29.02M -$88.86M -$165.0M -$180.7M -$313.4M -$33.23M
Investing Cash Flow $44.30M $57.58M $71.04M $57.86M -$232.2M -$20.59M
Common Stock Issued $19K $108K $253K $503K $1.25M $294K
Financing Cash Flow $19K $108K $253K $503K $311.1M $39.60M
Net Change in Cash $4.47M -$3.60M $1.77M -$18.14M $21.84M -$28.30M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.42M -$7.46M -$7.67M -$6.63M -$7.14M -$8.56M -$11.04M -$15.94M
Depreciation & Amortization $66K $171K $203K $255K $290K $347K $399K $426K
Stock-Based Compensation $506K $552K $545K $1.04M $407K $625K $709K $1.18M
Operating Cash Flow -$3.08M -$6.54M -$8.02M -$7.16M -$9.73M -$9.60M -$13.37M -$14.43M
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$14.43M
Purchases of Investments $0 $0 -$1.23M -$11.84M -$1.72M -$14.46M -$992K -$13.25M
Investing Cash Flow $4.00M $7.77M $7.92M $1.07M $17.88M $10.79M $14.55M $12.23M
Common Stock Issued $0 $19K $6.0K $5.0K $0 $14K $0 --
Financing Cash Flow $0 $19K $6.0K $5.0K $0 $14K $0 $29K
Net Change in Cash $922K $1.25M -$94K -$6.08M $8.15M $1.21M $1.19M -$2.17M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -469.3% -949.9% -967.4% -1576.6% -7364.1% -21290.9%
Net Profit Margin -433.7% -820.8% -878.6% -1537.8% -7824.7% -26289.2%
Return on Equity (ROE) -125.9% -110.4% -61.4% -51.4% -39.4% --
Return on Assets (ROA) -58.8% -63.4% -43.3% -38.7% -32.0% -130.5%
Current Ratio 3.59x 3.20x 5.17x 7.47x 8.87x 2.25x
Quick Ratio 3.77x 4.43x 6.29x 8.34x 8.73x 2.03x
Debt to Equity 0.87x 0.44x 0.18x 0.13x 0.10x --
Revenue Growth (YoY) +0.1% -2.4% +37.5% +354.7% +445.5% --
5Y Revenue / Share Growth +3354.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1098.0% -654.5% -492.8% -469.3% -884.4% -1312.3% -1871.1% -949.9%
Net Profit Margin -1034.4% -614.9% -461.7% -433.7% -821.6% -1217.0% -1741.3% -820.8%
Return on Equity (ROE) -305.8% -231.6% -154.7% -125.9% -133.0% -130.6% -135.3% -110.4%
Return on Assets (ROA) -73.6% -71.9% -62.5% -58.8% -65.6% -67.2% -73.8% -63.4%
Current Ratio 2.05x 2.61x 3.32x 3.59x 3.57x 3.11x 3.13x 3.20x
Quick Ratio 1.80x 2.30x 3.08x 3.77x 3.89x 3.94x 4.28x 4.43x
Debt to Equity 2.44x 1.73x 1.15x 0.87x 0.73x 0.62x 0.53x 0.44x
Revenue Growth (YoY) -100.0% -99.7% -97.9% -- +90.1% +41.5% -76.8% -100.0%
Source: SEC EDGAR CompanyFacts (CIK 0001641281) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:06 UTC · Open in terminal